EU Body Warns on Amgen (JOBS), Johnson & Johnson (JOBS) Anemia Drugs in Cancer Patients

June 27, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON, June 26 (Reuters) - Epoetin, or Epo, drugs should carry a new warning for their use in cancer patients stating that blood transfusion should be the preferred method of correcting anaemia, the European Medicines Agency said on Thursday.

Twitter
LinkedIn
Facebook
Email
Print

Europe

Amgen Johnson & Johnson Family of Companies